Edgestream Partners, L.P. Bio Rad Laboratories, Inc. Transaction History

Edgestream Partners, L.P.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$304.11 - $351.99 $2.47 Million - $2.86 Million	-8,134 Reduced 90.06%	898 $310,000
Q4 2023 Feb 14, 2024	BUY	$269.37 - $365.04 $1.01 Million - $1.37 Million	3,754 Added 71.13%	9,032 $2.92 Million
Q3 2023 Nov 14, 2023	BUY	$350.25 - $422.63 $1.85 Million - $2.23 Million	5,278 New	5,278 $1.89 Million
Q1 2023 May 15, 2023	BUY	$418.69 - $503.0 $319,041 - $383,286	762 New	762 $365,000
Q3 2022 Nov 14, 2022	BUY	$412.59 - $563.26 $2.83 Million - $3.86 Million	6,857 Added 380.31%	8,660 $3.61 Million
Q2 2022 Aug 12, 2022	BUY	$463.67 - $597.16 $835,997 - $1.08 Million	1,803 New	1,803 $892,000
Q3 2021 Nov 15, 2021	SELL	$657.71 - $825.77 $328,197 - $412,059	-499 Closed	0 $0
Q2 2021 Aug 10, 2021	SELL	$576.64 - $649.04 $4.34 Million - $4.88 Million	-7,526 Reduced 93.78%	499 $322,000
Q1 2021 May 06, 2021	BUY	$547.01 - $662.35 $4.39 Million - $5.32 Million	8,025 New	8,025 $4.58 Million

458

18.2M

19.5K

13.9K

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $8.42B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

Get notified when there are updates to the investment portfolio of Edgestream Partners, L.P., based on Form 13F filings with the SEC.

Stay updated on Edgestream Partners, L.P. with notifications on news.